Insider Trading April 21, 2026 06:25 PM

Ouster CTO Disposes of $3.31 Million in Shares After Exercising Options

Mark Frichtl sold 120,000 OUST shares under a Rule 10b5-1 plan following option exercises as the company posts a strong fourth quarter

By Caleb Monroe OUST
Ouster CTO Disposes of $3.31 Million in Shares After Exercising Options
OUST

Ouster Chief Technology Officer Mark Frichtl sold 120,000 shares of common stock across April 20-21, 2026, raising roughly $3.31 million under a previously established Rule 10b5-1 plan. The sales followed the exercise of 120,000 non-qualified stock options and leave Frichtl with 712,297 shares outstanding. The transactions occur as Ouster stock has risen sharply over the last year and after the company reported better-than-expected fourth-quarter 2025 results.

Key Points

  • Mark Frichtl sold 120,000 Ouster shares on April 20-21, 2026 under a Rule 10b5-1 plan, generating approximately $3,308,667.
  • Prior to selling, Mr. Frichtl exercised 120,000 non-qualified stock options at $2.13 per share, with a total exercise value of about $255,600; he now directly holds 712,297 shares.
  • Ouster reported better-than-expected Q4 2025 results - EPS $0.06 versus an expected loss of $0.14, and revenue of about $62.18 million versus $40.5 million consensus - and has seen a 310% stock gain over the past year.

Ouster, Inc. (NASDAQ: OUST) Chief Technology Officer Mark Frichtl completed sales of 120,000 shares of common stock on April 20 and April 21, 2026, generating proceeds of approximately $3,308,667. The dispositions were executed under a pre-arranged Rule 10b5-1 trading plan that was put in place on December 15, 2025.


The transactions were split into four equal blocks of 30,000 shares. On April 20, the first tranche of 30,000 shares was sold at a weighted average price of $26.0849 per share, with trade prices in that block ranging from $26.00 to $26.29. Later that same day, Mr. Frichtl sold another 30,000 shares at a weighted average of $27.0753 per share, with prices between $27.00 and $27.23.

On April 21, two further blocks of 30,000 shares each were sold. The first of these was executed at a weighted average price of $28.1111 per share, with individual sale prices from $28.00 to $28.44. The final block on April 21 was sold at a weighted average price of $29.0176 per share, with prices in that block ranging from $29.00 to $29.25.


Preceding these sales, Mr. Frichtl acquired the same number of shares through the exercise of non-qualified stock options. On April 20 he exercised 60,000 options at an exercise price of $2.13 per share. On April 21 he exercised an additional 60,000 options at the same $2.13 exercise price. The filings indicate that these options were fully vested and exercisable. The aggregate value corresponding to the shares acquired through exercise was approximately $255,600.

After the series of option exercises and subsequent sales, Mr. Frichtl is recorded as directly owning 712,297 shares of Ouster common stock.


The insider activity comes against a broader market backdrop in which Ouster shares have climbed sharply over the past year. The stock has gained roughly 310% over the prior 12 months and was trading at $27.61 at the time of the report, with a market capitalization of about $1.73 billion. Analysis from InvestingPro cited in connection with the company indicates the shares appear overvalued relative to their Fair Value and noted the stock is in overbought territory.


Separately, the company recently released fourth-quarter 2025 results that outperformed both earnings and revenue expectations. Ouster reported earnings per share of $0.06, compared with an expected loss of $0.14. Quarterly revenue totaled roughly $62.18 million versus a consensus estimate of $40.5 million.

Following the results, Cantor Fitzgerald reiterated an Overweight rating on Ouster, highlighting the company’s reported revenue of $62 million and a gross margin of 60%, both cited as above expectations. Oppenheimer raised its price target for Ouster to $40, citing the strength of the fourth-quarter results and constructive guidance tied to the company’s acquisition of Stereolabs.

Ouster also announced a leadership appointment in connection with its go-to-market organization. Cyrille Jacquemet was named Chief Revenue Officer and will continue to lead global sales and marketing efforts. Company disclosures note a string of product revenue expansion - twelve consecutive quarters of product revenue growth - and show annual revenue rising from $11 million in 2019 to $169 million in 2025.


This sequence of option exercises, insider sales, and strong quarterly performance leaves Mr. Frichtl with a significant direct ownership stake while the company navigates elevated market valuation metrics following recent gains.

Risks

  • Valuation concerns: InvestingPro analysis cited in the report indicates the stock appears overvalued relative to Fair Value and is in overbought territory - a market valuation risk for equity investors.
  • Insider disposition: The sales of 120,000 shares by the CTO, even under a prearranged plan, may prompt investor questions about near-term insider liquidity and timing - a potential market perception risk.
  • Concentration of outcomes: While the company beat Q4 expectations and reported strong revenue growth, future performance will influence whether recent gains and upgraded analyst views are sustained - an execution risk affecting investors across equity and technology market segments.

More from Insider Trading

CrowdStrike CEO George Kurtz Sells $2.13M in Stock Under Prearranged Plan Apr 21, 2026 Third Rock Ventures Sells $17.1M Stake in Rapport Therapeutics Apr 21, 2026 Astera Labs CEO Sells $57.85 Million in Stock; Holdings and Analyst Views Highlighted Apr 21, 2026 Aehr Test Systems Director Scott Gates Disposes $5.66 Million in Shares Apr 21, 2026 Arista Networks CTO Kenneth Duda Sells $9.47M in Stock as Shares Trade Near 52-Week High Apr 21, 2026